Orchid Pharma Ltd
Orchid Pharma | 524372
ORCHPHARMA - Share Price Chart
Stock Performance
Ratios
About Company
- Orchid Pharma Limited, is a vertically integrated pharmaceutical company with established research, manufacturing and marketing capabilities across multi-therapeutic domains
- Orchid's world class manufacturing infrastructure include USFDA compliant API and Finished Dosage Form facilities at Chennai in India
- The Company has dedicated state-of-art and GLP compliant R&D infrastructure for Process Research, Drug Discovery and Pharmaceutical Research at Chennai
- The Company is a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well as in drug discovery, which was incorporated on 1st July 1992 as a 100% Export Oriented Unit (EOU)
- Orchid has two manufacturing sites for APIs (at Alathur near Chennai and at Aurangabad, near Mumbai) and three manufacturing sites for Dosage forms (at Irungattukottai and Alathur in Chennai), besides two R&D centres (at Sholinganallur and Irungattukottai, Chennai), all are state-of-the-art and have several international regulatory approvals, including the US FDA and UK MHRA
- Orchid's API facilities are ISO certified for their quality, environmental management and operational health and safety systems
- Orchid has a Joint Venture in China for manufacturing sterile APIs
- The Company commenced its operation in the year 1994, also in the same year; orchid had entered into an agreement with SBD Laboratories Italy for technology for keeping production in sterile condition
- Orchid became the youngest Indian pharmaceutical company to be awarded the ISO 9002 certification in 1997
- During the same year of 1997, the company made a tie-up with Technology Innovative Industry of Italy and also launched a range of new products in the steriles category
Ethics: Orchid Pharma Ltd is flagged for
Animal Cruelty
The company engages directly in some form of animal cruelty through its business.
Adequate
The company demonstrates adequate ESG practices with room for improvement.
Research Calls
Technical Indicators
Pivot Points
Volume Analysis
Growth Rate
All figures in ₹ Crores
No Information Available
No shareholding data available at this time.
No Data Available
No Block Deals data available for this company.
News
No Information Available
Peers
#IndiaInvests
Trusted by 2.5 lac + Indians for their wealth-building needs
Top Losers
Group Stocks
Frequently Asked Questions
What is Share Price of Orchid Pharma Ltd?
The current share price of Orchid Pharma Ltd (Orchid Pharma) is ₹981.20. This price reflects the latest market valuation and is updated in real-time during trading hours.
What is the P/E Ratio of Orchid Pharma Ltd?
The Price-to-Earnings (P/E) ratio of Orchid Pharma Ltd is 339.54. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.
What is the 52-week high and low of Orchid Pharma Ltd?
Orchid Pharma Ltd has a 52-week high of ₹1143.50 and a 52-week low of ₹480.00. This range shows the stock's price volatility over the past year.
What is the Dividend Yield of Orchid Pharma Ltd?
Orchid Pharma Ltd offers a dividend yield of 0.00%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.
What is the EPS of Orchid Pharma Ltd?
The Earnings Per Share (EPS) of Orchid Pharma Ltd is ₹3.02. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.
What is the ROE of Orchid Pharma Ltd?
Orchid Pharma Ltd has a Return on Equity (ROE) of 1.49%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.
Disclaimer:
Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.
